LENZ Therapeutics Profit Margin

The latest profit margin for LENZ is -586.74% as of June 2026. That compares with -1047.96% in the prior-year period — up 44.0% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside LENZ Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, LENZ's profit margin moved from -1047.96% to -586.74% — a 44.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in LENZ Therapeutics's valuation or profitability profile.

Against Healthcare companies, LENZ currently prints -586.74% for profit margin, while the sector average sits near 21.34%. That is roughly 2850.1% below the sector mean. Large gaps often invite a closer look at LENZ Therapeutics's growth, margins, and balance sheet.

Profit Margin shows how effectively LENZ Therapeutics converts resources into returns. At -586.74%, LENZ may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1047.96% in the prior-year period — up 44.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting LENZ's profit margin (-586.74%), review year-over-year change from -1047.96%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.